Collectively, these findings suggest that breast epithelial cells in tissues of BRCA1-mutation carriers also exhibit misregulation of SIRT1 expression as well as DDR and pRb pathway activation before the onset of cancer. This evidence concerns the gene BRCA1 and cancer.